This protocol describes a survival procedure for safe and well-tolerated murine bilateral renal lymphadenectomy.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
This protocol describes a survival procedure for safe and well-tolerated murine bilateral renal lymphadenectomy.
Autoimmune diseases are the result of immune cells inappropriately targeting self-tissue, leading to pathology and damage to vital organs. Secondary lymphoid organs serve as a site for B and T cell activation and peripheral immune tolerance, consequent to antigen drainage and antigen-presenting cell (APC) trafficking through local lymphatics. The role of local draining lymph nodes as the initial site of lymphocyte activation has been described in settings of tumors, infection, and organ-specific autoimmune diseases, but not in systemic autoimmunity. Systemic lupus erythematosus, one such disease, is a widespread autoimmune disease with common kidney involvement leading to kidney injury and eventual failure. Further understanding of the role of renal lymph nodes, which are the primary site of antigen draining and APC trafficking from the kidneys, is limited by an inability to selectively perturb this tissue. Described here is a survival procedure for safe and well-tolerated murine bilateral renal lymphadenectomy. Included are detailed instructions, visual aids, helpful tips for improved success, and troubleshooting procedural pitfalls. Long-term survival is excellent and has been observed for at least 4 months postoperatively. Resected renal lymph nodes are intact and immediately ready for downstream processing. This procedure is best suited for studies of the local effect of renal lymph nodes.
Autoimmune diseases span every organ in the human body from relatively organ-restricted diseases like autoimmune hepatitis, uveitis, and type 1 diabetes to widespread diseases like systemic sclerosis and sjögrens1,2,3,4,5. Immunologic tolerance is a critical stage in B and T cell development to prevent self-reactivity6. While central tolerance via clonal deletion in the thymus is necessary and effective, this alone leaves gaps in the defense against autoimmunity7,8. Peripheral tolerance is a secondary barrier to self-reactivity via B and T cell anergy, deletion, or T cell exhaustion, which takes place in secondary lymphoid organs, including regional tissue-draining lymph nodes following antigen drainage9,10. However, it is also becoming increasingly clear that autoreactive cells may reside within and migrate from these lymph nodes in individuals who are genetically and/or environmentally susceptible following inappropriate activation11,12.
Systemic lupus erythematosus is one such autoimmune disease, with clear B and T cell involvement in multiple organ systems13. A particularly common and morbid manifestation of which is lupus nephritis and progression to end-stage renal disease14. The ability to understand the direct effect of the locally residing B and T cells in autoimmune-driven kidney disease, in contrast to circulating systemic pathophysiology, is currently limited by an inability to selectively perturb these nodes. With this gap in mind, a survival procedure for the murine bilateral renal lymphadenectomy was developed and is described here.
The overall goal of this protocol is to achieve safe and reliable excision of bilateral renal lymph nodes in mice with high postoperative survival and tolerance. This procedure would be best suited for studies of the local effect of renal lymph nodes on priming, activating, and tolerizing immune cells associated with kidney disease. This procedure is ideal when combined with autoimmune or oncologic models affecting the kidney.
Access restricted. Please log in or start a trial to view this content.
All procedures are performed in compliance with Yale Institutional Animal Care and Use Committee protocols. To develop this procedure, 8-12-week-old Balb/c strain, Lupus-prone mice (MRL/MpJ-Faslpr/J /J) and age/sex/genotype matched sham controls were utilized15. In addition, 8-12-week-old wild type C57BL/6 strain mice were also tested, and nodes were safely resected. Both male and female mice were included. The reagents and the equipment used are listed in the Table of Materials.
1. Preparation of instruments, animals, and the operating room

Figure 1: Anatomical positioning of mouse and organs and optional Evans Blue injection. (A) Animal positioning and securing for left renal exposure. (B) Anatomical orientation within operative windows. The left renal lymph node chain can be found adjacent to the adrenal vessels and aorta, superior to the renal vessels. The right renal lymph node can be found just superior to the renal vessels. (C) Animal positioning and securing for right renal exposure. (D-G) Implementation of 20 μL 5% Evans Blue injection. (D) Left hindfoot and left renal lymph node chain (white arrow) prior to dye. Note the general location of the cisterna chyli (dashed box), which is often transparent and/or difficult to identify unless plump with lymph. (E) Left hindfoot and left renal lymph node chain (white arrow) 5 min after dye injection. Note afferent lymphatic vessels (black arrow). (F) Right hindfoot and right renal lymph node (white arrow) prior to dye. G) Right hindfoot and right renal lymph node (white arrow) 5 min after dye injection. Note afferent lymphatic vessels (black arrows). Scale bars: A,C = 1.0 cm; D-G (hindfoot views) = 0.5 cm; D-G (internal views) = 0.1 cm. Please click here to view a larger version of this figure.
2. Left renal lymphadenectomy

Figure 2: Left renal lymphadenectomy. (A) Left oblique incision just inferior and posterior to the splenic shadow. (B) Identifying the spleen superiorly (white line), left adrenal posteriorly (black arrow), and left kidney inferiorly (black line). (C) A plane into the retroperitoneum is created by bluntly dissecting immediately posterior to the kidney (black arrow). (D) The left renal lymph node (white arrows) is immediately visible within a sheath of adipose. (E) A plane is created between the nearby vessels and the node (white arrows). (F) The node is gently retracted and sharply excised along the plane created. (G) Hemostasis is confirmed, and the empty space (faded arrows from (D)) where the lymph node (white arrow) previously lived is noted to be free of any residual lymph node. (H) The left lymph node is often a chain of multiple nodes (white arrows). Inset is an ex vivo left lymph node chain (1 mm x 3.5 mm). Scale bars: 0.2 cm. Tick = 1 mm. Please click here to view a larger version of this figure.
3. Right renal lymphadenectomy

Figure 3: Right renal lymphadenectomy. (A) Right oblique incision just inferior and posterior to the ultimate rib. (b) The liver edge is identified superiorly (white line) and the left kidney inferiorly (black line). The right adrenal is hidden by the liver edge. (C) A plane into the retroperitoneum is created by bluntly dissecting immediately posterior to the kidney (black arrow). (D) The right renal lymph node (white arrows) is immediately visible within a sheath of adipose. (E) A plane is then created around the node (white arrow). (F) The node is gently retracted and sharply excised along the plane created. (G) Hemostasis is confirmed, and the empty space (faded arrows from (D)) where the lymph node (white arrow) previously lived is noted to be free of any residual lymph node. (H) The right lymph node is a single, spherical node (white arrow). Inset is an ex vivo lymph node (2 mm x 1.5 mm). Scale bars: 0.2 cm. Tick = 1 mm. Please click here to view a larger version of this figure.
4. Postoperative care
5. Lymph node handling
NOTE: The excised lymph node is immediately ready to enter pipelines for further downstream applications.
Access restricted. Please log in or start a trial to view this content.
This procedure can be performed in 15-20 min per mouse. To confirm the accuracy of this procedure, bilateral renal lymphadenectomies were performed on five 8-12 week-old, age, sex, and genotype-matched littermates. All mice tolerated the procedure well with 100% perioperative survival. Excised samples were placed in PBS on ice. All samples immediately sunk, confirming low adipose content. Excised samples (and four separate visceral adipose controls) were then crushed through a 100 µm cell strainer and washed with PBS. Ce...
Access restricted. Please log in or start a trial to view this content.
Described here is a survival procedure for safe and well-tolerated murine bilateral renal lymphadenectomy. The major limitation of this procedure is the relatively small size of renal lymph nodes, necessitating an operating microscope. Without an operating microscope, confident resection can be difficult to achieve. Some genetic mouse models have enlarged lymph nodes, making identification and technique learning easier17. In otherwise healthy, wild-type mice, lymph nodes can be small and difficult...
Access restricted. Please log in or start a trial to view this content.
R.A.F. is an advisor to Glaxo Smith Kline, Plythera Inc., and Ventus Therapeutics. All other authors declare no competing interests.
We acknowledge J. Alderman, B. Cadugan, E. Hughes-Picard, and J. Horrocks for administrative assistance, and to C. Hughes for mouse colony management. H.N.B. is a fellow of the Yale Surgeon Scientist Training Program, which partially funded and supported this project. This work was also funded by the Howard Hughes Medical Institute (to R.A.F.) and the American College of Surgeons Resident Research Award (to H.N.B.).
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Anesthesia circuit | Any | Or injectable anesthetic | |
| BD LSRII flow cytometer (or equivalent) | BD Biosciences | Equipped with FACS Diva Software | |
| Buprenorphine XR | Any | For analgesia | |
| Cell culture media | Any | (for live cell techniques; ie. DMEM or RPMI) | |
| DAPI | Biolegend | 422801 | Working concentration: 15 ug/mL |
| Dual/twin gooseneck microscope LED lights | Any | ||
| Ethanol (70% in water) | Any | For cleaning | |
| FITC-conjugated anti-mouse CD45.2 (104) | Biolegend | 109806 | Working concentration: 5 ug/mL |
| Forceps: Angled fine-tipped forceps (x2) | Roboz | RS-5058 | Material: Dumoxel; Pattern #5, 45 degree angle; tip size 0.1 X 0.06mm |
| Forceps: Fine-tipped forceps | Roboz | RS-4960 | Material: Dumostar; Pattern #1; Tip size: 0.20 X 0.12mm |
| Forceps: Fine-tipped forceps | Roboz | RS-4966 | Material: Dumostar, Biologie tip; Pattern #3; Tip size: 0.08 x0.04mm |
| Lidocaine | Any | For analgesia | |
| Mice | Jax | For C57BL/6 strain, wild type mice: The jackson laboratories #000664 | |
| Needle drivers | Roboz | RS-6410 | Castroviejo needle holder; Straight |
| Operating microscope | Leica | MZ9.5 | Leica Mz9.5 stereo head operating microscope |
| OPTIONAL: Evans Blue dye | Sigma | E2129-10G | For lymph tracing. |
| Phosphate-buffered saline (PBS) | Any | ||
| Povidone/Iodine solution | Any | For skin preparation/sterilization | |
| Scissors: Extra fine-tipped scissors | Roboz | RS-5605 | McPherson-Vannas; 3mm cutting edge; curved |
| Scissors: Medium scissors | Roboz | RS-5676 | Noyes; 13mm cutting edge; straight |
| Surgical glue | Any | e.g. 3M Vetbond tissue adhesive | |
| Suture: 6-0 blue monofilament polypropylene | Any | ||
| Tissue fixative | Any | (for planned histology; ie. 10% neutral buffered formalin or 4% paraformaldehyde) | |
| Warm-water circulating heating pad | Any | ||
| Mice | The Jackson laboratories | For Balb/c strain, Lupus prone mice (MRL/MpJ-Fas-lpr/J): #000485 |
Access restricted. Please log in or start a trial to view this content.